Valuation: Bayer AG

Market Cap 48.58B 55.97B 45.48B 41.61B 78.44B 5,324B 79.61B 532B 209B 2,669B 210B 206B 8,870B P/E 2026 *
21x
P/E 2027 * 16.1x
Enterprise Value 77.79B 89.63B 72.82B 66.63B 126B 8,525B 127B 852B 334B 4,273B 336B 329B 14,203B EV / Sales 2026 *
1.7x
EV / Sales 2027 * 1.62x
Free-Float
100%
Yield 2026 *
0.32%
Yield 2027 * 1.07%
1 day-0.16%
1 week+3.62%
Current month+1.90%
1 month-7.45%
3 months+29.94%
6 months+6.54%
Current year+33.08%
1 week 47.13
Extreme 47.13
50.36
1 month 45.73
Extreme 45.73
52
Current year 33.07
Extreme 33.07
53.74
1 year 25
Extreme 25
53.74
3 years 18.5
Extreme 18.5
53.74
5 years 18.5
Extreme 18.5
67.95
10 years 18.5
Extreme 18.5
123.82
Manager TitleAgeSince
Chief Executive Officer 60 2023-05-31
Director of Finance/CFO 57 2026-05-31
Chief Tech/Sci/R&D Officer 59 2021-01-31
Director TitleAgeSince
Director/Board Member 56 2012-03-31
Director/Board Member 60 2017-03-31
Chairman 68 2020-04-27
Change 5-day change 1-year change 3-year change Capi.($)
-0.16%+3.62% - - 55.83B
+1.89%-1.49%+55.62%+165.18% 1,043B
-0.24%-3.22%+50.51%+52.02% 621B
-0.95%-7.38%+22.83%+65.08% 435B
0.00%+0.83%+42.80%+37.60% 361B
+0.58%-3.51%+31.12%+40.54% 293B
-1.55%-9.78%+5.61%+8.62% 251B
-0.73%+4.44%+34.91%+66.41% 220B
-0.24%-13.15%-4.02%-44.69% 201B
-0.68%-1.41%+16.36%+66.32% 164B
Average -0.32%-3.81%+28.42%+50.79% 398.79B
Weighted average by Cap. -0.22%-3.79%+37.57%+77.18%

Financials

2026 *2027 *
Net sales 45.72B 52.68B 42.8B 39.16B 73.82B 5,011B 74.92B 501B 196B 2,511B 198B 193B 8,348B 46.94B 54.09B 43.95B 40.21B 75.8B 5,145B 76.93B 514B 202B 2,579B 203B 199B 8,572B
Net income 2.17B 2.5B 2.03B 1.86B 3.5B 238B 3.55B 23.75B 9.32B 119B 9.37B 9.17B 396B 2.92B 3.36B 2.73B 2.5B 4.71B 320B 4.78B 31.94B 12.53B 160B 12.61B 12.33B 532B
Net Debt 29.21B 33.65B 27.34B 25.02B 47.16B 3,201B 47.86B 320B 126B 1,604B 126B 124B 5,333B 27.34B 31.5B 25.6B 23.42B 44.15B 2,997B 44.81B 300B 118B 1,502B 118B 116B 4,992B
Logo Bayer AG
Bayer AG is one of the world's leaders in designing, producing, and marketing pharmaceutical products and agrochemicals. Net sales are distributed by product family as follows: - agrochemicals (47.5%): herbicides, fungicides, insecticides, etc.; - pharmaceutical products (39.1%): intended for the prevention and treatment of cardiovascular and respiratory diseases, diabetes, nervous system disorders, etc.; - OTC products and nutritional supplements (12.7%); - other (0.7%). Net sales are distributed geographically as follows: Germany (5.7%), Switzerland (1%), Europe-Middle East-Africa (22.9%), United States (33.1%), North America (3.6%), China (7.6%), Asia-Pacific (8.9%), Brazil (9.6%), and Latin America (7.6%).
Employees
87,830
Date Price Change Volume
26-08-06 €49.31 +0.02% 4,255
26-08-05 €49.30 +1.80% 6,250
26-08-04 €48.43 +2.22% 8,793
26-08-03 €47.38 -1.90% 3,490
26-07-31 €48.30 -0.06% 1,739
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
49.40EUR
Average target price
56.81EUR
Spread / Average Target
+14.99%

Quarterly revenue - Rate of surprise